Psoriatic Arthritis at IDC 2027

Psoriatic Arthritis (PsA) is a chronic inflammatory joint condition that often accompanies psoriasis, a skin disorder characterized by red, scaly patches. PsA manifests with joint pain, stiffness, swelling, and limited movement, commonly affecting the fingers, toes, wrists, knees, and ankles. It may also involve the spine, leading to spondylitis. While the exact cause of PsA remains uncertain, it likely involves a combination of genetic predisposition, immune system dysregulation, and environmental factors. Diagnosing PsA typically involves a thorough medical history, physical examination, imaging studies (such as X-rays and MRI scans), and blood tests to rule out other conditions. Early diagnosis and treatment are crucial to prevent joint damage and disability. Treatment approaches aim to alleviate inflammation, manage symptoms, and enhance quality of life. Options include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), biologic therapies, corticosteroids, and physical therapy. Lifestyle adjustments like maintaining a healthy weight, regular exercise, stress reduction, and abstaining from smoking can also help manage symptoms and promote overall well-being. Given its potential impact on daily functioning and well-being, a collaborative healthcare team involving dermatologists, rheumatologists, physical therapists, and other specialists is essential for effective PsA management.